Hikma Pharmaceuticals (LON:HIK) Stock Passes Above 200-Day Moving Average – Here’s What Happened

Hikma Pharmaceuticals PLC (LON:HIK)’s share price crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 1,444.83 and traded as high as GBX 1,541. Hikma Pharmaceuticals shares last traded at GBX 1,540, with a volume of 1,728,501 shares changing hands.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on the stock. Berenberg Bank reissued a “buy” rating and issued a GBX 1,800 target price on shares of Hikma Pharmaceuticals in a report on Tuesday, April 28th. Jefferies Financial Group lifted their price target on shares of Hikma Pharmaceuticals from GBX 1,850 to GBX 1,870 and gave the company a “buy” rating in a report on Tuesday, May 5th. Finally, Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and issued a GBX 195 price target on shares of Hikma Pharmaceuticals in a research note on Monday, June 22nd. Five investment analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the stock currently has an average rating of “Buy” and an average target price of GBX 1,687.

Hikma Pharmaceuticals Price Performance

The company has a market capitalization of £3.27 billion, a PE ratio of 8.51, a price-to-earnings-growth ratio of 2.38 and a beta of 0.65. The firm’s 50 day simple moving average is GBX 1,445.11 and its 200 day simple moving average is GBX 1,444.83. The company has a quick ratio of 1.27, a current ratio of 1.82 and a debt-to-equity ratio of 61.84.

Hikma Pharmaceuticals Company Profile

At Hikma we help put better health within reach, every day. By creating high-quality medicines and making them accessible to the people who need them, we help to shape a healthier world that enriches all our communities. We help deliver this by living our culture, delivering our strategy, and acting responsibly. We are a trusted, reliable partner and dependable source of over 820+ (as of Feb 2026) high-quality generic, specialty and branded pharmaceutical products that hospitals, physicians and pharmacists need to treat their patients across North America, MENA and Europe.